Cite
HARVARD Citation
Bignon, L. et al. (2018). Efficacy of anthracycline/taxane‐based neo‐adjuvant chemotherapy on triple‐negative breast cancer in BRCA1/BRCA2 mutation carriers. Breast journal. 24 (3), pp. 269-277. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bignon, L. et al. (2018). Efficacy of anthracycline/taxane‐based neo‐adjuvant chemotherapy on triple‐negative breast cancer in BRCA1/BRCA2 mutation carriers. Breast journal. 24 (3), pp. 269-277. [Online].